NCT00081809Phase 2Completed
A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma
Study sponsor: Agenus Inc. · AGEN
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2005-06Actual
Enrollment · participants35
Source updated2023-09-28Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.